SCHEMBL6164720

SCHEMBL6164720

[c]1cccc2c(CN3CCOCC3)nccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 2/20 0.45
L3MBTL1 Q9Y468 4/20 0.42
NPC1 O15118 2/20 0.42
METAP2 P50579 1/20 0.42
RAB9A P51151 1/20 0.42
PAX8 Q06710 1/20 0.42
CXCR4 P61073 1/20 0.41
KDM4E B2RXH2 4/20 0.40
GAA P10253 2/20 0.40
HPGD P15428 2/20 0.40
GLA P06280 1/20 0.40
HSD17B10 Q99714 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 2/20 0.38
MCL1 Q07820 1/20 0.38
NCF1 P14598 1/20 0.38
MAPT P10636 3/20 0.37
LMNA P02545 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167055 0.84 SIGMAR1 (0.40) KMT2AMEN1CXCR4NCF1LMNA
SCHEMBL6167504 0.84 CYP2A13 (0.36) ALDH1A1KMT2AMEN1NPC1RAB9A
SCHEMBL5659986 0.71 L3MBTL1 (0.40) ALDH1A1KMT2AL3MBTL1NPC1RAB9A
SCHEMBL6168733 0.69 CXCR4 (0.45) ALDH1A1KMT2AMEN1L3MBTL1NPC1
SCHEMBL4902515 0.68 CYP2C19 (0.71) ALDH1A1KMT2AMEN1L3MBTL1NPC1
SCHEMBL20160984 0.68 CYP2A13 (0.57) ALDH1A1KMT2AMEN1L3MBTL1NPC1
SCHEMBL10035128 0.68 EGLN1 (0.60) ALDH1A1KMT2AMEN1CXCR4CYP2A13
SCHEMBL6164398 0.67 FLT1 (0.38)
SCHEMBL31428721 0.67 ALDH1A1 (0.69) ALDH1A1KMT2AMEN1L3MBTL1NPC1
SCHEMBL6015944 0.67 BCHE (0.48) ALDH1A1KMT2AMEN1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1417177-A4 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL MYERS SQUIBB PHARMA CO (US) 2005-10-19 EP disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed
EP-1417177-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Bristol-Myers Squibb Pharma Company (US) 2004-05-12 EP disclosed
WO-2003007883-A2 ACYLSEMICARBAZIDES AS CYCLIN DEPENDENT KINASE INHIBITORS USEFUL AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2003-01-30 WO disclosed
CN-1297442-A 5-aminoindeno [1,2-c] pyrazol-4-ones as anti-cancer and anti-proliferative agents DU PONT PHARM CO (US) 2001-05-30 CN disclosed
EP-1071668-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS Du Pont Pharmaceuticals Company (US) 2001-01-31 EP disclosed
WO-1999054308-A1 5-AMINOINDENO(1,2-C)PYRAZOL-4-ONES AS ANTI-CANCER AND ANTI-PROLIFERATIVE AGENTS DU PONT PHARMACEUTICALS COMPANY (US) 1999-10-28 WO disclosed